Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.14 - $0.39 $54 - $152
390 Added 201.03%
584 $0
Q2 2023

Aug 14, 2023

BUY
$0.69 - $1.46 $133 - $283
194 New
194 $0
Q3 2022

Nov 14, 2022

BUY
$1.53 - $2.77 $203 - $368
133 New
133 $0

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.